UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 7, 2020 4:01 P.M.

Form:	S-1
CIK: 0001744659 Company Name: Akero Therapeutics, Inc. File Number: 333-239685